Prognostic value of chronic inflammatory cell infiltrates in Dukes stage B and C colorectal cancer.

被引:0
|
作者
Christie, M.
Prakash, S.
Jorissen, R. N.
Sakthianandeswaren, A.
Gibbs, P.
Lipton, L. R.
Desai, J.
Tie, J.
Kerr, D. J.
Sieber, O.
机构
[1] Royal Melbourne Hosp, Ludwig Inst Canc Res, Ludwig Colon Canc Initiat Lab, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Anat Pathol Dept, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[4] Western Hosp, Melbourne, Vic, Australia
[5] Canc Trials Australia, Melbourne, Vic, Australia
[6] Royal Melbourne Hosp, Melbourne, Vic, Australia
[7] Univ Oxford, Dept Clin Pharmacol, Oxford, England
关键词
D O I
10.1200/jco.2010.28.15_suppl.e14003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14003
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Prognostic value of the lymph node ratio in stage In colorectal cancer
    Ren, Jing-Qing
    Liu, Jian-Wei
    Chen, Zhi-Tang
    Liu, Shao-Jie
    Huang, Shi-Jie
    Huang, Yong
    Hong, Jing-Song
    CHINESE JOURNAL OF CANCER, 2012, 31 (05) : 241 - 247
  • [42] Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis
    Diamantis, N.
    Xynos, I. D.
    Amptulah, S.
    Karadima, M.
    Skopelitis, H.
    Tsavaris, N.
    JOURNAL OF BUON, 2013, 18 (01): : 105 - 115
  • [43] Mesothelin expression has prognostic value in stage / colorectal cancer
    Shiraishi, Takehiro
    Shinto, Eiji
    Mochizuki, Satsuki
    Tsuda, Hitoshi
    Kajiwara, Yoshiki
    Okamoto, Koichi
    Einama, Takahiro
    Hase, Kazuo
    Ueno, Hideki
    VIRCHOWS ARCHIV, 2019, 474 (03) : 297 - 307
  • [44] Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer
    Takehiro Shiraishi
    Eiji Shinto
    Satsuki Mochizuki
    Hitoshi Tsuda
    Yoshiki Kajiwara
    Koichi Okamoto
    Takahiro Einama
    Kazuo Hase
    Hideki Ueno
    Virchows Archiv, 2019, 474 : 297 - 307
  • [45] Prognostic value of PD-L1 expression in colorectal cancer.
    Lin, Albert Y.
    Kouzminova, Natalia B.
    Chou, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] CONTRIBUTION OF PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS TO THE SURVIVAL PROGNOSIS OF PATIENTS WITH DUKES STAGE-B AND STAGE-C COLORECTAL-CANCER
    GANESH, S
    SIER, CFM
    HEERDING, MM
    VANKRIEKEN, JHJM
    GRIFFIOEN, G
    VANDEVELDE, CJH
    LAMERS, CBHW
    VERSPAGET, HW
    GASTROENTEROLOGY, 1995, 108 (04) : A472 - A472
  • [47] Prognostic value of quantitative alterations in chromosome 17 and 18 in colorectal cancer.
    Muñoz-Navas, MA
    Sola, J
    Duque, JM
    Panizo, A
    Macías, E
    Betés, MT
    Súbtil, JC
    Herráiz, MT
    de la Riva, S
    Blanco, JJ
    GASTROENTEROLOGY, 1998, 114 (04) : A649 - A649
  • [48] Prognostic value of RAS, BRAF, and PIK3CA mutations in early-stage colorectal cancer.
    Byer, Jennifer Elizabeth
    Kothari, Nishi
    Juan, TzuHua
    Teer, Jamie K.
    Schell, Michael J.
    Shibata, David
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] Influence of allogeneic blood transfusion on outcome in patients with Dukes B stage of colorectal cancer
    Zdravkovic, D.
    Bilanovic, D.
    Randjelovic, T.
    Granic, M.
    Djukanovic, B.
    Nikolic, D.
    Ivanovic, N.
    Dikic, S.
    Toskovic, B.
    Zdravkovic, M.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : S118 - S118
  • [50] BLOOD-TRANSFUSION AND PROGNOSIS IN DUKES B AND C COLORECTAL-CANCER
    BENTZEN, SM
    BALSLEV, I
    PEDERSEN, M
    TEGLBJAERG, PS
    HANBERGSORENSEN, F
    BONE, J
    JACOBSEN, NO
    SELL, A
    OVERGAARD, J
    BERTELSEN, K
    HAGE, E
    FENGER, C
    KRONBORG, O
    HANSEN, L
    HOSTRUP, H
    NORGAARDPEDERSEN, B
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) : 457 - 463